查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1401908

2030 年病毒學檢測市場預測：按產品類型、技術、診斷技術、方法、應用、最終用戶和地區進行的全球分析

Virology Testing Market Forecasts to 2030 - Global Analysis By Product Type, Procedure, Diagnostic Technique, Method, Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的數據，2023 年全球病毒學檢測市場規模為 127 億美元，預計預測期內複合年成長率為 3.8%，到 2030 年將達到 164 億美元。

病毒學檢測是指用於檢測、識別和研究生物樣本中病毒的診斷過程和實驗室技術。這些測試有助於識別特定病毒的存在，確定病毒的類型和病毒株，並評估對病毒感染的免疫反應。此外，病毒學檢測可以幫助確定感染者最有效的抗病毒治療方法，並有助於制定管理病毒性疾病的個人化醫療方法。病毒學檢測對於篩檢捐血是否有愛滋病毒、B型肝炎和C型肝炎等血源性病毒以及確保輸血安全至關重要。

根據世界衛生組織（WHO）預測，2021年全球60%的人口將患有感染疾病。

病毒感染疾病增加

全球病毒感染疾病日益流行是病毒學檢測市場成長的關鍵因素。流感、HIV、肝炎以及最近的 COVID-19 大大流行等感染疾病的持續出現，推動了對準確、及時的診斷解決方案的需求。隨著病毒感染持續對公共衛生構成嚴重挑戰，迫切需要能夠快速識別和區分各種病毒的先進病毒學檢測方法。此外，病毒學檢測在疾病監測中發揮至關重要的作用，幫助衛生專業人員就治療、遏制措施和公共衛生干預措施做出明智的資訊。

高成本

病毒學檢測的高成本是病毒學檢測市場的主要抑制因素，影響了醫療保健提供者和患者的可用性和負擔能力。先進的病毒學檢測方法，特別是PCR（聚合酶鍊式反應）和次世代定序等分子診斷技術，通常涉及昂貴的試劑、設備和技術人員。與病毒學檢測相關的經濟負擔可能導致檢測延遲、監測不足和病毒感染漏報。此外，它可能會阻礙強力的公共衛生策略的製定，並阻礙有效控制和管理病毒爆發的能力。

技術進步

在病毒學檢測市場，技術進步正在徹底改變診斷能力，提高病毒檢測的準確性和效率。聚合酶鍊式反應（PCR）技術大大改進，使得快速、準確地鑑定病毒的遺傳物質成為可能。此外，創新的即時檢測設備的開發促進了更快、更分散的診斷，特別是在大流行期間。自動化和機器人化簡化了實驗室工作流程，縮短了周轉時間並提高了測試吞吐量。這些技術進步在全球健康中發揮著至關重要的作用，不僅有助於病毒感染的早期和準確診斷，而且還支持監測活動和加強大流行的防範。

抗生素抗藥性

抗生素抗藥性是病毒學檢測市場中重要但間接的問題。病毒學檢測主要著重於識別和診斷未經抗生素治療的病毒感染。然而，在臨床實踐中，當病毒感染疾病患者錯誤地服用抗生素時，就會出現問題。濫用或過度使用抗生素會導致抗生素抗藥性的產生，這是細菌進化以抵抗抗生素作用的現象。如果無法有效地進行病毒學檢測來確定感染疾病的病毒性質，則可能會不必要地開立抗生素。這種管理不善會助長抗生素抗藥性，並對公共衛生構成廣泛威脅。

COVID-19 的影響

COVID-19大流行對病毒學檢測市場產生了重大影響，推動了全球對診斷解決方案的前所未有的需求。迫切需要大規模檢測來識別病毒並阻止其傳播，導致各種病毒學檢測方法的採用激增，包括 PCR 檢測、抗原檢測和血清學檢測。這種不斷成長的需求正在推動新測試技術的快速創新和開發。

細胞培養方法領域預計在預測期內規模最大

細胞培養方法部分估計佔據最大佔有率。細胞培養方法是病毒學檢測的基礎和必備技術，在病毒分離、傳播和研究中發揮至關重要的作用。該過程以病毒樣本接種細胞，並為病毒生長和複製提供最佳條件。當病毒在宿主細胞內繁殖時，可能會發生可觀察到的變化，包括細胞毒性作用。細胞培養能夠辨識和表徵病毒，可用於診斷分析、疫苗和抗病毒藥物的開發。此外，它將促進病毒行為和發病機制的研究，以及潛在治療性介入的評估。

預計被動預防在預測期內的複合年成長率最高。

預計被動預防領域將在預測期內出現良好成長。被動預防在病毒學檢測市場中發揮著至關重要的作用，它與診斷檢測一起提供了補充策略來預防和控制病毒感染。在病毒學檢測的背景下，被動預防是針對有接觸特定病毒風險的個體的預防措施。病毒學檢測市場受益於被動預防的整合，它為病毒感染控制提供了全面的方法。此外，隨著對有效抗病毒解決方案的需求不斷成長，被動預防有助於形成多方面的策略，並加強了醫療保健專業人員可用於預防和治療的工具套件。

佔有率最高的地區

由於尖端測試和診斷技術的快速採用、醫療保健支出的增加、支持性政府法規的存在、最先進的臨床實驗室的存在以及存在，北美預計將成為預測期內最大的市場製造公司。我們得到了市場佔有率。推動市場擴張的另一個重要因素是美國公共和私人機構研發活動的活性化。

複合年成長率最高的地區：

由於診斷和醫療保健領域的顯著成長和進步，預計亞太地區在預測期內將出現有益成長。醫療保健意識的提高、醫療保健成本的上升以及醫療保健基礎設施的改善正在推動對病毒學檢測的需求。亞太地區正在爆發感染疾病，需要高效、快速的病毒學檢測來及早發現和遏制。對預防性醫療保健和公共衛生措施的日益重視進一步增加了該地區對病毒學檢測解決方案的需求。

免費客製化服務：

如果您訂閱此報告，我們將為您提供以下免費自訂選項之一：

  • 公司簡介
    • 其他市場參與企業的綜合分析（最多 3 家公司）
    • 主要企業SWOT分析（最多3家企業）
  • 區域分割
    • 根據客戶興趣對主要國家的市場估計/預測/複合年成長率（註：基於可行性檢查）
  • 競爭基準化分析
    • 根據產品系列、地理分佈和策略聯盟對主要企業基準化分析

目錄

第1章執行摘要

第2章 前言

  • 概述
  • 相關利益者
  • 調查範圍
  • 調查方法
    • 資料探勘
    • 資料分析
    • 資料檢驗
    • 研究途徑
  • 研究資訊來源
    • 主要研究資訊來源
    • 二次研究資訊來源
    • 先決條件

第3章市場趨勢分析

  • 介紹
  • 促進因素
  • 抑制因素
  • 機會
  • 威脅
  • 產品分析
  • 應用分析
  • 最終用戶分析
  • 新興市場
  • 新型冠狀病毒感染疾病（COVID-19）的影響

第4章波特五力分析

  • 供應商的議價能力
  • 買方議價能力
  • 替代品的威脅
  • 新進入者的威脅
  • 競爭公司之間的敵對關係

第5章全球病毒學檢測市場：依產品類型

  • 介紹
  • 檢測套件
  • 裝置
  • 消耗品

第6章全球病毒學檢測市場：依方法論

  • 介紹
  • 抗原檢測
  • 細胞培養方法
  • 特異性抗體檢測
  • 基因序列測定
  • 病毒核酸檢測
  • 血凝試驗

第7章全球病毒學檢測市場：依診斷技術分類

  • 介紹
  • 基於免疫檢測的方法
  • 基於質譜的方法
  • 分子診斷方法
    • 基於NGS的方法
    • 基於PCR的方法
  • 其他診斷技術

第8章全球病毒學檢測市場：依方法

  • 介紹
  • 被動預防
  • 積極預防
  • 免疫預防
  • 干擾素
  • 抗病毒化療

第9章全球病毒學檢測市場：依應用分類

  • 介紹
  • 呼吸道感染疾病
  • 皮膚和軟組織感染疾病
  • 尿道感染
  • 胃腸道感染疾病
  • 性行為感染傳染病
  • 眼部感染疾病
  • 周產期感染疾病

第10章全球病毒學測試市場：依最終用戶分類

  • 介紹
  • 診所
  • 醫院
  • 診斷中心
  • 實驗室
  • 血庫
  • 藥局

第11章全球病毒學檢測市場：按地區

  • 介紹
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 歐洲其他地區
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 其他亞太地區
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地區
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 卡達
    • 南非
    • 中東和非洲其他地區

第12章 主要進展

  • 合約、夥伴關係、協作和合資企業
  • 收購和合併
  • 新產品發布
  • 業務擴展
  • 其他關鍵策略

第13章 公司簡介

  • Bio-Rad Laboratories Inc
  • Abbot Healthcare
  • F. Hoffmann-La Roche AG
  • Fujirebio Diagnostics Inc.
  • Cepheid
  • Hologic Inc.
  • Thermo Fisher Scientific Inc.
  • Qiagen
  • bioMerieux SA
  • Siemens Healthineers
  • Diasorin
  • Trinity Biotech
  • Vircell
  • Biospherix, Ltd
  • Novogene Co Ltd.
Product Code: SMRC24428

According to Stratistics MRC, the Global Virology Testing Market is accounted for $12.7 billion in 2023 and is expected to reach $16.4 billion by 2030 growing at a CAGR of 3.8% during the forecast period. Virology testing refers to the diagnostic processes and laboratory techniques used to detect, identify, and study viruses in biological samples. These tests help identify the presence of specific viruses, determine the type and strain of the virus, and assess the immune response to viral infections. Moreover, virology testing assists in determining the most effective antiviral treatments for infected individuals, contributing to personalized medicine approaches to managing viral diseases. Virology testing is essential in screening blood donations for the presence of blood-borne viruses such as HIV, hepatitis B, and hepatitis C, ensuring the safety of blood transfusions.

According to the World Health Organization (WHO), in 2021, 60% of the global population was suffering from infectious diseases.

Market Dynamics:

Driver:

Rising prevalence of viral infections

The increasing prevalence of viral infections worldwide is a significant driver for the growth of the virology testing market. The persistent emergence of infectious diseases, including influenza, HIV, hepatitis, and, more recently, the global COVID-19 pandemic, has heightened the demand for accurate and timely diagnostic solutions. As viral infections continue to pose significant public health challenges, there is a pressing need for advanced virology testing methods that can swiftly identify and differentiate various viruses. Moreover, virology testing plays a pivotal role in disease surveillance, aiding healthcare professionals in making informed decisions regarding treatment, containment measures, and public health interventions.

Restraint:

High cost

The high cost of virology tests is a significant restraint in the virology testing market, impacting accessibility and affordability for both healthcare providers and patients. Advanced virology testing methods, particularly molecular diagnostic techniques like PCR (Polymerase Chain Reaction) and next-generation sequencing, often involve expensive reagents, equipment, and skilled personnel. The financial burden associated with virology testing may lead to delays in testing, inadequate surveillance, and underreporting of viral infections. Moreover, it could impede the development of robust public health strategies, hindering the ability to effectively control and manage viral outbreaks.

Opportunity:

Technological advancements

In the virology testing market, technological advancements have revolutionized diagnostic capabilities, enhancing the precision and efficiency of virus detection. Polymerase chain reaction (PCR) techniques have undergone significant refinements, enabling the rapid and accurate identification of viral genetic material. Furthermore, the development of innovative point-of-care testing devices has facilitated quicker and more decentralized diagnostics, particularly during pandemics. Automation and robotics have streamlined laboratory workflows, reducing turnaround times and enhancing testing throughput. These technological strides not only contribute to the early and precise diagnosis of viral infections but also play a pivotal role in global health by supporting surveillance efforts and bolstering pandemic preparedness.

Threat:

Antibiotic resistance

Antibiotic resistance is a critical concern within the virology testing market, albeit indirectly. Virology testing primarily focuses on identifying and diagnosing viral infections, which are not treated with antibiotics. However, the issue arises in clinical practice when patients with viral infections are mistakenly prescribed antibiotics. The misuse and overuse of antibiotics contribute to the development of antibiotic resistance, a phenomenon where bacteria evolve to withstand the effects of these medications. If virology tests are not employed effectively to identify the viral nature of an infection, antibiotics may be unnecessarily prescribed. This mismanagement fuels antibiotic resistance, posing a broader threat to public health.

COVID-19 Impact

The COVID-19 pandemic has profoundly impacted the virology testing market, triggering unprecedented demand for diagnostic solutions worldwide. The urgent need for large-scale testing to identify and contain the spread of the virus has led to a surge in the adoption of various virology testing methods, including PCR assays, antigen tests, and serological tests. This increased demand has prompted rapid innovation and the development of new testing technologies.

The cell culture method segment is expected to be the largest during the forecast period

The cell culture method segment is estimated to hold the largest share. The cell culture method is a fundamental and indispensable technique in virology testing, playing a pivotal role in the isolation, propagation, and study of viruses. The process involves inoculating the cells with a viral sample and providing optimal conditions for viral growth and replication. As the virus multiplies within the host cells, observable changes, such as cytopathic effects, may occur. Cell culture allows for the identification and characterization of viruses, aiding in the development of diagnostic assays, vaccines, and antiviral drugs. Additionally, it facilitates the study of viral behavior, pathogenesis, and the evaluation of potential therapeutic interventions.

The passive prophylaxis segment is expected to have the highest CAGR during the forecast period

The passive prophylaxis segment is anticipated to have lucrative growth during the forecast period. Passive prophylaxis plays a pivotal role in the virology testing market, offering a complementary strategy alongside diagnostic testing to prevent and manage viral infections. In the context of virology testing, passive prophylaxis serves as a preventive measure for individuals at risk of exposure to specific viruses. The virology testing market benefits from the integration of passive prophylaxis by offering a comprehensive approach to viral infection management. Moreover, as the demand for effective antiviral solutions continues to grow, passive prophylaxis contributes to a multi-faceted strategy, enhancing the arsenal of tools available to healthcare professionals for both prevention and treatment.

Region with largest share:

North America commanded the largest market share during the extrapolated period due to the quick adoption of cutting-edge testing and diagnostic techniques, increased healthcare spending, the existence of supportive government regulations, the existence of cutting-edge clinical laboratories, and the existence of manufacturing firms. Another significant element boosting the market's expansion is the rise in R&D activity from both public and private institutions in the US.

Region with highest CAGR:

Asia Pacific is expected to witness profitable growth over the projection period, owing to significant growth and advancements in diagnostics and healthcare. The increasing awareness of healthcare, rising healthcare expenditures, and improvements in healthcare infrastructure drive the demand for virology testing. The Asia-Pacific region also experiences outbreaks of infectious diseases, necessitating efficient and rapid virology testing for early detection and containment. The growing emphasis on preventive healthcare and the implementation of public health initiatives further fuel the demand for virology testing solutions in this region.

Key players in the market:

Some of the key players in the Virology Testing Market include Bio-Rad Laboratories Inc, Abbot Healthcare, F. Hoffmann-La Roche AG, Fujirebio Diagnostics Inc. , Cepheid, Hologic Inc., Thermo Fisher Scientific Inc., Qiagen, bioMerieux SA, Siemens Healthineers, Diasorin, Trinity Biotech, Vircell, Biospherix, Ltd and Novogene Co Ltd.

Key Developments:

In August 2023, Abbott has partnered with Redcliffe Labs to launch Clinical Decision Support (CDS), also known as AlinIQ, which is powered by unique technologies such as Big Data Engines and Artificial Intelligence (AI).

In February 2022, Abbott, the global healthcare leader, announced new collaborations with key health-tech partners BeatO, Sugar.fit, PharmEasy, GOQii, 1MG, Zyla Health, Healthifyme and Fitterfly to usher a new era of holistic diabetes management care.

Product Types Covered:

  • Assay Kits
  • Instruments
  • Consumables

Procedures Covered:

  • Antigen Detection
  • Cell Culture Method
  • Specific Antibodies Detection
  • Gene Sequencing
  • Virus Nucleic Acid Detection
  • Hemagglutination Assays

Diagnostic Techniques Covered:

  • Immunoassay-based Method
  • Mass Spectroscopy-based Method
  • Molecular Diagnostics Method
  • Other Diagnostic Techniques

Methods Covered:

  • Passive Prophylaxis
  • Active Prophylaxis
  • Immunoprophylaxis
  • Interferon's
  • Antiviral Chemotherapy

Applications Covered:

  • Respiratory Tract Infections
  • Skin and Soft Tissue Infections
  • Urinary Tract Infection
  • GI Tract Infections
  • Sexually Transmitted Diseases
  • Eye Infections
  • Perinatal Infections

End Users Covered:

  • Clinics
  • Hospitals
  • Diagnostic Centers
  • Laboratories
  • Blood Banks
  • Pharmacies

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 Application Analysis
  • 3.8 End User Analysis
  • 3.9 Emerging Markets
  • 3.10 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Virology Testing Market, By Product Type

  • 5.1 Introduction
  • 5.2 Assay Kits
  • 5.3 Instruments
  • 5.4 Consumables

6 Global Virology Testing Market, By Procedure

  • 6.1 Introduction
  • 6.2 Antigen Detection
  • 6.3 Cell Culture Method
  • 6.4 Specific Antibodies Detection
  • 6.5 Gene Sequencing
  • 6.6 Virus Nucleic Acid Detection
  • 6.7 Hemagglutination Assays

7 Global Virology Testing Market, By Diagnostic Technique

  • 7.1 Introduction
  • 7.2 Immunoassay-based Method
  • 7.3 Mass Spectroscopy-based Method
  • 7.4 Molecular Diagnostics Method
    • 7.4.1 NGS-based methods
    • 7.4.2 PCR-based methods
  • 7.5 Other Diagnostic Techniques

8 Global Virology Testing Market, By Method

  • 8.1 Introduction
  • 8.2 Passive Prophylaxis
  • 8.3 Active Prophylaxis
  • 8.4 Immunoprophylaxis
  • 8.5 Interferon's
  • 8.6 Antiviral Chemotherapy

9 Global Virology Testing Market, By Application

  • 9.1 Introduction
  • 9.2 Respiratory Tract Infections
  • 9.3 Skin and Soft Tissue Infections
  • 9.4 Urinary Tract Infection
  • 9.5 GI Tract Infections
  • 9.6 Sexually Transmitted Diseases
  • 9.7 Eye Infections
  • 9.8 Perinatal Infections

10 Global Virology Testing Market, By End User

  • 10.1 Introduction
  • 10.2 Clinics
  • 10.3 Hospitals
  • 10.4 Diagnostic Centers
  • 10.5 Laboratories
  • 10.6 Blood Banks
  • 10.7 Pharmacies

11 Global Virology Testing Market, By Geography

  • 11.1 Introduction
  • 11.2 North America
    • 11.2.1 US
    • 11.2.2 Canada
    • 11.2.3 Mexico
  • 11.3 Europe
    • 11.3.1 Germany
    • 11.3.2 UK
    • 11.3.3 Italy
    • 11.3.4 France
    • 11.3.5 Spain
    • 11.3.6 Rest of Europe
  • 11.4 Asia Pacific
    • 11.4.1 Japan
    • 11.4.2 China
    • 11.4.3 India
    • 11.4.4 Australia
    • 11.4.5 New Zealand
    • 11.4.6 South Korea
    • 11.4.7 Rest of Asia Pacific
  • 11.5 South America
    • 11.5.1 Argentina
    • 11.5.2 Brazil
    • 11.5.3 Chile
    • 11.5.4 Rest of South America
  • 11.6 Middle East & Africa
    • 11.6.1 Saudi Arabia
    • 11.6.2 UAE
    • 11.6.3 Qatar
    • 11.6.4 South Africa
    • 11.6.5 Rest of Middle East & Africa

12 Key Developments

  • 12.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 12.2 Acquisitions & Mergers
  • 12.3 New Product Launch
  • 12.4 Expansions
  • 12.5 Other Key Strategies

13 Company Profiling

  • 13.1 Bio-Rad Laboratories Inc
  • 13.2 Abbot Healthcare
  • 13.3 F. Hoffmann-La Roche AG
  • 13.4 Fujirebio Diagnostics Inc.
  • 13.5 Cepheid
  • 13.6 Hologic Inc.
  • 13.7 Thermo Fisher Scientific Inc.
  • 13.8 Qiagen
  • 13.9 bioMerieux SA
  • 13.10 Siemens Healthineers
  • 13.11 Diasorin
  • 13.12 Trinity Biotech
  • 13.13 Vircell
  • 13.14 Biospherix, Ltd
  • 13.15 Novogene Co Ltd.

List of Tables

  • Table 1 Global Virology Testing Market Outlook, By Region (2021-2030) ($MN)
  • Table 2 Global Virology Testing Market Outlook, By Product Type (2021-2030) ($MN)
  • Table 3 Global Virology Testing Market Outlook, By Assay Kits (2021-2030) ($MN)
  • Table 4 Global Virology Testing Market Outlook, By Instruments (2021-2030) ($MN)
  • Table 5 Global Virology Testing Market Outlook, By Consumables (2021-2030) ($MN)
  • Table 6 Global Virology Testing Market Outlook, By Procedure (2021-2030) ($MN)
  • Table 7 Global Virology Testing Market Outlook, By Antigen Detection (2021-2030) ($MN)
  • Table 8 Global Virology Testing Market Outlook, By Cell Culture Method (2021-2030) ($MN)
  • Table 9 Global Virology Testing Market Outlook, By Specific Antibodies Detection (2021-2030) ($MN)
  • Table 10 Global Virology Testing Market Outlook, By Gene Sequencing (2021-2030) ($MN)
  • Table 11 Global Virology Testing Market Outlook, By Virus Nucleic Acid Detection (2021-2030) ($MN)
  • Table 12 Global Virology Testing Market Outlook, By Hemagglutination Assays (2021-2030) ($MN)
  • Table 13 Global Virology Testing Market Outlook, By Diagnostic Technique (2021-2030) ($MN)
  • Table 14 Global Virology Testing Market Outlook, By Immunoassay-based Method (2021-2030) ($MN)
  • Table 15 Global Virology Testing Market Outlook, By Mass Spectroscopy-based Method (2021-2030) ($MN)
  • Table 16 Global Virology Testing Market Outlook, By Molecular Diagnostics Method (2021-2030) ($MN)
  • Table 17 Global Virology Testing Market Outlook, By NGS-based methods (2021-2030) ($MN)
  • Table 18 Global Virology Testing Market Outlook, By PCR-based methods (2021-2030) ($MN)
  • Table 19 Global Virology Testing Market Outlook, By Other Diagnostic Techniques (2021-2030) ($MN)
  • Table 20 Global Virology Testing Market Outlook, By Method (2021-2030) ($MN)
  • Table 21 Global Virology Testing Market Outlook, By Passive Prophylaxis (2021-2030) ($MN)
  • Table 22 Global Virology Testing Market Outlook, By Active Prophylaxis (2021-2030) ($MN)
  • Table 23 Global Virology Testing Market Outlook, By Immunoprophylaxis (2021-2030) ($MN)
  • Table 24 Global Virology Testing Market Outlook, By Interferon's (2021-2030) ($MN)
  • Table 25 Global Virology Testing Market Outlook, By Antiviral Chemotherapy (2021-2030) ($MN)
  • Table 26 Global Virology Testing Market Outlook, By Application (2021-2030) ($MN)
  • Table 27 Global Virology Testing Market Outlook, By Respiratory Tract Infections (2021-2030) ($MN)
  • Table 28 Global Virology Testing Market Outlook, By Skin and Soft Tissue Infections (2021-2030) ($MN)
  • Table 29 Global Virology Testing Market Outlook, By Urinary Tract Infection (2021-2030) ($MN)
  • Table 30 Global Virology Testing Market Outlook, By GI Tract Infections (2021-2030) ($MN)
  • Table 31 Global Virology Testing Market Outlook, By Sexually Transmitted Diseases (2021-2030) ($MN)
  • Table 32 Global Virology Testing Market Outlook, By Eye Infections (2021-2030) ($MN)
  • Table 33 Global Virology Testing Market Outlook, By Perinatal Infections (2021-2030) ($MN)
  • Table 34 Global Virology Testing Market Outlook, By End User (2021-2030) ($MN)
  • Table 35 Global Virology Testing Market Outlook, By Clinics (2021-2030) ($MN)
  • Table 36 Global Virology Testing Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 37 Global Virology Testing Market Outlook, By Diagnostic Centers (2021-2030) ($MN)
  • Table 38 Global Virology Testing Market Outlook, By Laboratories (2021-2030) ($MN)
  • Table 39 Global Virology Testing Market Outlook, By Blood Banks (2021-2030) ($MN)
  • Table 40 Global Virology Testing Market Outlook, By Pharmacies (2021-2030) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.